Isolated reduction of haematocrit does not compromise in vitro blood coagulation

被引:68
作者
Iselin, BM
Willimann, PFX
Seifert, B
Casutt, M
Bombeli, T
Zalunardo, MP
Pasch, T
Spahn, DR
机构
[1] Univ Zurich Hosp, Inst Anasthesiol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Dept Biostat, CH-8006 Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Internal Med, Div Haematol, Zurich, Switzerland
关键词
blood; coagulation; blood haemodilution; haematocrit; transfusion;
D O I
10.1093/bja/87.2.246
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Low haematocrit values are generally well tolerated in terms of oxygen transport but a low haematocrit might interfere with blood coagulation. We thus sampled 60 ml of blood in 30 healthy volunteers. The blood was centrifuged for 30 min at 2000 g and separated into plasma, which contained the platelet fraction, and packed red blood cells. The blood was subsequently reconstituted by combining the entire plasma fraction with a mixture of packed red blood cells, 0.9% saline, so that the final haematocrit was either 40, 30, 20, or 10%. Blood coagulation was assessed by computerized Thrombelastograph(R) analysis. Data were compared using repeated measures analysis of variance and post-hoc paired t-tests with Bonferroni correction. Decreasing the haematocrit from 40 to 10% resulted in a shortening of reaction time (r) and coagulation time (k), and an increase in angle cc, maximum amplitude (MA) and clot strength (G) (all P<0.02). This pattern represents acceleration of blood coagulation with low haematocrit values. The isolated reduction in haematocrit, therefore, does not compromise in vitro blood coagulation.
引用
收藏
页码:246 / 249
页数:4
相关论文
共 27 条
[1]   REVERSAL OF POSTREPERFUSION COAGULOPATHY BY PROTAMINE SULFATE IN ORTHOTOPIC LIVER-TRANSPLANTATION [J].
BAYLY, PJM ;
THICK, M .
BRITISH JOURNAL OF ANAESTHESIA, 1994, 73 (06) :840-842
[2]   Citrate storage affects Thrombelastograph® analysis [J].
Camenzind, V ;
Bombeli, T ;
Seifert, B ;
Jamnicki, M ;
Popovic, D ;
Pasch, T ;
Spahn, DR .
ANESTHESIOLOGY, 2000, 92 (05) :1242-1249
[3]   Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding [J].
Chau, TN ;
Chan, YW ;
Patch, D ;
Tokunaga, S ;
Greenslade, L ;
Burroughs, AK .
GUT, 1998, 43 (02) :267-271
[4]  
Crowley JP, 1997, AM J CLIN PATHOL, V108, P579
[5]   Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation [J].
Egli, GA ;
Zollinger, A ;
Seifert, B ;
Popovic, D ;
Pasch, T ;
Spahn, DR .
BRITISH JOURNAL OF ANAESTHESIA, 1997, 78 (06) :684-689
[6]   Does the platelet-activated clotting test (HemoSTATUS(R)) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass? [J].
Ereth, MH ;
Nuttall, GA ;
Klindworth, JT ;
MacVeigh, I ;
Santrach, PJ ;
Orszulak, TA ;
Harmsen, WS ;
Oliver, WC .
ANESTHESIA AND ANALGESIA, 1997, 85 (02) :259-264
[7]   A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care [J].
Hébert, PC ;
Wells, G ;
Blajchman, MA ;
Marshall, J ;
Martin, C ;
Pagliarello, G ;
Tweeddale, M ;
Schweitzer, I ;
Yetisir, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :409-417
[8]   Low- and medium-molecular-weight hydroxyethyl starches - Comparison of their effect on blood coagulation [J].
Jamnicki, M ;
Bombeli, T ;
Seifert, B ;
Zollinger, A ;
Camenzind, V ;
Pasch, T ;
Spahn, DR .
ANESTHESIOLOGY, 2000, 93 (05) :1231-1237
[9]  
Kang YG, 1995, SEMIN THROMB HEMOST, V21, P34
[10]   Monitoring platelet glycoprotein IIb/IIIa fibrin interaction with tissue factor-activated thromboelastography [J].
Khurana, S ;
Mattson, JC ;
Westley, S ;
ONeill, WW ;
Timmis, GC ;
Safian, RD .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (04) :401-411